Full name
GP BIONICS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
GP BIONICS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. AUGUSTA CIESZKOWSKIEGO 1/3 / 125, 01-636 WARSZAWA
TAX ID5252700136
Rate company:
GP BIONICS SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID5252700136
KRS0000664723
Share capital5,000.00 zł
address
UL. AUGUSTA CIESZKOWSKIEGO 1/3 / 125, 01-636 WARSZAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
5252700136
REGON
366614900
KRS
0000664723
Legal form
limited liability company
Register Address
UL. AUGUSTA CIESZKOWSKIEGO 1/3 / 125, 01-636 WARSZAWA
Date of registration in KRS
2017-02-21
Date of commencement of economic activity
2017-02-21
Act signature
RDF/671113/24/648
Pkd codes
72.11.Z - Research and experimental development on biotechnology
21.20.Z - Manufacture of medicines and other pharmaceutical products
26.60.Z - Manufacture of irradiation, electromedical and electrotherapeutic equipment
32.50.Z - Manufacture of medical and dental instruments and supplies
71.20.B - Other technical testing and analysis
72.20.Z - Research and experimental development on social sciences and humanities
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
86.10.Z - Hospital activities
86.22.Z - Specialist medical practice activities
Payer VAT status
Unregirestered
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | -0 | -0 | -0 | -98,8 |
EBITDA | -0 | -0 | -0 | -98,8 |
Short time liabilities | 0,2 | 0,4 | 0,5 | 19,8 |
Equity capital | -0 | -0 | -0,1 | -109,6 |
Operating profit (EBIT) | -0 | -0 | -0 | -98,8 |
Assets | 2,6 | 2,8 | 2,8 | 1,4 |
Net profit (loss) | -0 | -0 | -0 | -98,8 |
Cash | 0,2 | 0 | 0 | -76,1 |
Net income from sale | 0 | 0 | 0 | 0 |
Liabilities and provisions for liabilities | 2,6 | 2,8 | 2,9 | 2,9 |
Working assets | 2,6 | 2,8 | 2,8 | 1,4 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 86,7 | 55,1 | 52,3 | -2,8 |
Equity capital to total assets | -0,7 | -1,4 | -2,9 | -1,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 2 147 483 648 | 2 147 483 648 | 2 147 483 648 | 0 |
Current financial liquidity indicator | 0.9934847354888916 | 0.9863422513008118 | 0.9721736907958984 | 0 |
Net dept to EBITDA | 13.79822826385498 | -2.0553205013275146 | -4.2702317237854 | -2,2 |
Financial statements
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
Bartosz Wasąg
Gdańsk
BioCraft Paweł Olszewski
Chwaszczyno
Molecular Biotech Mateusz Gielata
Warszawa
BIOCELTIX SPÓŁKA AKCYJNA
WROCŁAW
FRONTLINE BIOSCIENCES SPÓŁKA AKCYJNA
WARSZAWA
Michał Ordak Ekspertstat
Warszawa